Stock Scorecard
Stock Summary for Organon & Company (OGN) - $14.51 as of 3/28/2025 8:36:33 PM EST
Total Score
14 out of 30
Safety Score
53 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for OGN
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for OGN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for OGN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for OGN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for OGN (53 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 8 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 10 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for OGN
Financial Details for OGN
Company Overview |
|
|---|---|
| Ticker | OGN |
| Company Name | Organon & Company |
| Country | USA |
| Description | Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2024 |
| Next Earnings Date | 4/30/2025 |
Stock Price History |
|
| Last Day Price | 14.51 |
| Price 4 Years Ago | 25.54 |
| Last Day Price Updated | 3/28/2025 8:36:33 PM EST |
| Last Day Volume | 1,865,939 |
| Average Daily Volume | 3,834,743 |
| 52-Week High | 22.29 |
| 52-Week Low | 13.62 |
| Last Price to 52 Week Low | 6.53% |
Valuation Measures |
|
| Trailing PE | 4.42 |
| Industry PE | 37.01 |
| Sector PE | 40.10 |
| 5-Year Average PE | 3.91 |
| Free Cash Flow Ratio | 4.90 |
| Industry Free Cash Flow Ratio | 11.91 |
| Sector Free Cash Flow Ratio | 47.05 |
| Current Ratio Most Recent Quarter | 1.70 |
| Total Cash Per Share | 2.96 |
| Book Value Per Share Most Recent Quarter | 1.83 |
| Price to Book Ratio | 8.04 |
| Industry Price to Book Ratio | 8.86 |
| Sector Price to Book Ratio | 21.92 |
| Price to Sales Ratio Twelve Trailing Months | 0.59 |
| Industry Price to Sales Ratio Twelve Trailing Months | 88.85 |
| Sector Price to Sales Ratio Twelve Trailing Months | 27.78 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 257,950,000 |
| Market Capitalization | 3,742,854,500 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/24/2025 |
| Previous Dividend Amount | 0.2800 |
| Current Dividend Amount | 0.2800 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 1.12 |
| Trailing Annual Dividend Yield | 7.31% |
| Forward Annual Dividend Rate | 1.12 |
| Forward Annual Dividend Yield | 7.31% |
| 5-Year Dividend Payments Count | 15 |
| 3-Year Average Dividend Yield | 7.65% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | 33.63% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -80.70% |
| Annual Earnings Growth | 11.56% |
| Reported EPS 12 Trailing Months | 3.33 |
| Reported EPS Past Year | 4.11 |
| Reported EPS Prior Year | 4.14 |
| Net Income Twelve Trailing Months | 1,301,000,000 |
| Net Income Past Year | 1,023,000,000 |
| Net Income Prior Year | 917,000,000 |
| Quarterly Revenue Growth YOY | -0.40% |
| 5-Year Revenue Growth | -0.33% |
| Operating Margin Twelve Trailing Months | 18.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 763,000,000 |
| Total Cash Past Year | 693,000,000 |
| Total Cash Prior Year | 706,000,000 |
| Net Cash Position Most Recent Quarter | -7,986,000,000 |
| Net Cash Position Past Year | -8,067,000,000 |
| Long Term Debt Past Year | 8,760,000,000 |
| Long Term Debt Prior Year | 8,913,000,000 |
| Total Debt Most Recent Quarter | 8,749,000,000 |
| Equity to Debt Ratio Past Year | -0.01 |
| Equity to Debt Ratio Most Recent Quarter | 0.05 |
| Total Stockholder Equity Past Year | -70,000,000 |
| Total Stockholder Equity Prior Year | -892,000,000 |
| Total Stockholder Equity Most Recent Quarter | 493,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,908,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 7.40 |
| Free Cash Flow Past Year | 1,782,000,000 |
| Free Cash Flow Prior Year | 1,316,000,000 |
Options |
|
| Put/Call Ratio | 0.97 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.07 |
| MACD Signal | 0.02 |
| 20-Day Bollinger Lower Band | 14.30 |
| 20-Day Bollinger Middle Band | 15.08 |
| 20-Day Bollinger Upper Band | 15.86 |
| Beta | 0.72 |
| RSI | 40.64 |
| 50-Day SMA | 17.53 |
| 150-Day SMA | 19.47 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 3/28/2025 3:52:11 AM EST |